Tools

The brains of people tripping on magic mushrooms have given the best picture yet of how psychedelic drugs work and… »   

Alexza Pharmaceuticals Inc said U.S. health regulators extended the review date for its novel anti-psychotic treatment by three months after… »   

When your health insurance provider denies an experimental treatment or a high-cost drug, how much are you willing to pay… »   

To no one’s surprise, the FDA has rejected dapagliflozin, an SGLT2 inhibitor for diabetes. The advisory panel voted it down… »   

In a setback that could spell trouble for several drugmakers developing a new type of diabetes pill, U.S. regulators have… »   

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic)… »   

Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of… »   

In 2005, news first broke that researchers in Scotland found unexpectedly low rates of cancer among diabetics taking metformin, a… »   

U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer… »   

Allergan Inc’s chief executive said he expects surgeons replacing faulty breast implants made by France’s now-defunct Poly Implant Prothese (PIP)… »